Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer [NA]
Completed clinical trial evaluating sentinel lymph node assessment after prior surgical biopsy in patients with early breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry
This clinical trial update summarizes the completion of a prospective observational registry assessing the use of eribulin for advanced brea…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Women's Health Initiative (WHI) [Phase 3]
The Women's Health Initiative Phase 3 trial status is completed. The update covers osteoporosis, breast cancer, colorectal cancer, and vario…
-
CLINICAL_TRIALS research · 2016-04-15Clinical Trial Update: Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer Patients
This update describes a completed pilot functional imaging study investigating the mechanisms of chronic pain in patients with breast cancer…
-
CLINICAL_TRIALS withdrawal · 2016-04-15Clinical Trial Update: Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer [Phase 2]
A Phase 2 neoadjuvant study of ACE (doxorubicin/cyclophosphamide followed by eribulin) for operable HER2-negative breast cancer has been wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Ph 1 ADI-PEG 20 Plus Doxorubicin; Patients With HER2 Negative Metastatic Breast Cancer [Phase 1]
This update reports on a Phase 1 trial of ADI-PEG 20 plus doxorubicin in patients with HER2-negative metastatic breast cancer; the study has…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: Risk Education and Assessment for Cancer Heredity [NA]
A completed University of Utah trial evaluating risk education and assessment for hereditary cancer predisposition, including breast and ova…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Effect of Soy Supplementation on Cellular Markers in Normal and Cancerous Breast Tissue: A Randomized Placebo Controlled Study [NA]
A completed randomized, placebo-controlled study examining how soy supplementation affects cellular markers in normal and cancerous breast t…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer
A completed clinical trial assessing the psycho-esthetic impact of tattoo-based areola reconstruction after breast cancer surgery.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Optical Detection of Malignancy During Percutaneous Interventions
A completed trial evaluating optical detection of malignancy during percutaneous interventions for lung lesions and liver metastases from co…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression [Phase 1, Phase 2]
Phase 1/2 trial evaluating trastuzumab combined with erlotinib as first-line therapy for metastatic breast cancer with HER2 overexpression h…
-
CLINICAL_TRIALS research · 2016-04-11Clinical Trial Update: Prevention of Post-Mastectomy Breast Pain Using Ambulatory Continuous Paravertebral Blocks [Phase 4]
A Phase 4 trial update notes the study evaluating ambulatory continuous paravertebral blocks for preventing postmastectomy pain has complete…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Premenopausal Endocrine Responsive Chemotherapy Trial [Phase 3]
A Phase 3 trial of a premenopausal endocrine-responsive chemotherapy regimen for breast cancer was terminated; results were posted on 2016-0…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen-sponsored trial evaluating neutropenia and anemia management in patients with solid tumors receiving myelotoxic chemotherapy has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: The Preemptive Analgesic Efficacy of Nefopam [NA]
This completed clinical trial evaluated the preemptive analgesic efficacy of nefopam in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
This completed clinical trial investigated risk factors and pathophysiological mechanisms for persistent pain after breast cancer treatment.
-
CLINICAL_TRIALS research · 2016-04-06Clinical Trial Update: A Multicenter Breast Cancer Biospecimen Registry
Description of a multicenter breast cancer biospecimen registry sponsored by Luminist, Inc. The current status of the study is unspecified.
-
CLINICAL_TRIALS other · 2016-04-06Clinical Trial Update: EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Expanded Access Protocol update for combining lapatinib with capecitabine in metastatic breast cancer, sponsored by Novartis.
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer [Phase 3]
Phase 3 trial update evaluating triptorelin in combination with exemestane or tamoxifen for premenopausal women with hormone-responsive brea…
-
FDA approval · 2016-04-04FDA Approved: CAPECITABINE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for CAPECITABINE submitted by BluePoint Laboratories. The action concerns the generic capecitabi…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Positron Emission Mammography (PEM) Biopsy Accessory for the Diagnosis of Breast Cancer [NA]
This entry notes a completed clinical trial evaluating a Positron Emission Mammography biopsy accessory for diagnosing breast cancer, with r…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with bevacizumab as first-line therapy in women with stage IV breast cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial comparing neurotoxicity of nab-paclitaxel versus conventional paclitaxel in metastatic breast cancer has completed. T…
-
CLINICAL_TRIALS research · 2016-03-29Clinical Trial Update: A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep) [NA]
A multicenter randomized trial is evaluating capecitabine versus endocrine therapy as maintenance after first-line capecitabine-based chemot…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment [NA]
The trial of digital breast tomosynthesis in the screening environment has completed and results were posted.